Catabasis raises $40 million to fund omega-3 linker platform
This article was originally published in Scrip
Executive Summary
Catabasis Pharmaceuticals has raised $39.6 million in a series A financing led by SV Life Sciences, Clarus Ventures and MedImmune Ventures, with Advanced Technology Ventures also participating.